Hyderabad: A Hyderabad-based biotech start-up, Utopia Therapeutics, has secured a United States patent for its pioneering immunotherapy-based obesity vaccine, marking a significant milestone ...
BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...
Mayo Clinic researchers and collaborators have identified a previously unrecognized way lung tumors weaken the immune system, ...
Over the past years, I have closely followed the evolution of the global oncology industry. What I have observed is steady, structural growth supported by science, policy support, and increasing ...
Obesity and related metabolic disorders such as fatty liver disease and high triglycerides are rising globally, with limited long-term treatment options ...
The FDA accepted the new drug application for iberdomide based on minimal residual disease negativity benefit shown in the ...
Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.
HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
The Oncology Nurse Advisor Summit spotlights CAR T-cell therapy, bispecific antibodies, and immunotherapy nursing best practices.
New disease-modifying agents are being evaluated in the clinic that could change the course of treatment for Alzheimer’s disease patients. Regulated industries like pharmaceuticals, biotech, and ...
Draft guidance from NICE recommends durvalumab before and after surgery for muscle-invasive bladder cancer following phase 3 trial survival data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results